FGF2 and breast neoplasm: Moreover, in a breast tumor mouse model obesity was associated with an increased release of FGF2 by adipocytes, whereas either the antidiabetic drug metformin or the inhibition of FGFR decreased the vessel density and restored the tumor sensitivity to anti-VEGF agents [115].